BVS

Bioventus Class A (BVS)

About Bioventus Class A (BVS)

Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.

Details

Daily high
$10.80
Daily low
$10.27
Price at open
$10.27
52 Week High
$14.38
52 Week Low
$3.90
Market cap
697.5M
Dividend yield
0.00%
Volume
538,525
Avg. volume
317,265
P/E ratio
-17.29

Bioventus Class A News

Details

Daily high
$10.80
Daily low
$10.27
Price at open
$10.27
52 Week High
$14.38
52 Week Low
$3.90
Market cap
697.5M
Dividend yield
0.00%
Volume
538,525
Avg. volume
317,265
P/E ratio
-17.29